153 related articles for article (PubMed ID: 32416712)
1. Theranostic Nanoparticles for Pancreatic Cancer Treatment.
Jaidev LR; Chede LS; Kandikattu HK
Endocr Metab Immune Disord Drug Targets; 2021; 21(2):203-214. PubMed ID: 32416712
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic Cancer Gene Therapy Delivered by Nanoparticles.
Kurtanich T; Roos N; Wang G; Yang J; Wang A; Chung EJ
SLAS Technol; 2019 Apr; 24(2):151-160. PubMed ID: 30395768
[TBL] [Abstract][Full Text] [Related]
3. Magnetic Nanoparticles in Cancer Theranostics.
Gobbo OL; Sjaastad K; Radomski MW; Volkov Y; Prina-Mello A
Theranostics; 2015; 5(11):1249-63. PubMed ID: 26379790
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable nanoparticles as theranostics of ovarian cancer: an overview.
Chaurasiya S; Mishra V
J Pharm Pharmacol; 2018 Apr; 70(4):435-449. PubMed ID: 29380366
[TBL] [Abstract][Full Text] [Related]
5. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
[TBL] [Abstract][Full Text] [Related]
6. Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy.
Zhu L; Staley C; Kooby D; El-Rays B; Mao H; Yang L
Cancer Lett; 2017 Mar; 388():139-148. PubMed ID: 27916607
[TBL] [Abstract][Full Text] [Related]
7. Advanced iron oxide nanotheranostics for multimodal and precision treatment of pancreatic ductal adenocarcinoma.
Zhu L; Mao H; Yang L
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1793. PubMed ID: 35396932
[TBL] [Abstract][Full Text] [Related]
8. Sequential Targeting TGF-β Signaling and KRAS Mutation Increases Therapeutic Efficacy in Pancreatic Cancer.
Pei Y; Chen L; Huang Y; Wang J; Feng J; Xu M; Chen Y; Song Q; Jiang G; Gu X; Zhang Q; Gao X; Chen J
Small; 2019 Jun; 15(24):e1900631. PubMed ID: 31033217
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-Based Combination Therapy for Cancer Treatment.
Yhee JY; Son S; Lee H; Kim K
Curr Pharm Des; 2015; 21(22):3158-66. PubMed ID: 26027570
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnology: Carrying drugs.
Bourzac K
Nature; 2012 Nov; 491(7425):S58-60. PubMed ID: 23320289
[No Abstract] [Full Text] [Related]
11. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
12. Calcium phosphate nanocarriers for drug delivery to tumors: imaging, therapy and theranostics.
Huang D; He B; Mi P
Biomater Sci; 2019 Oct; 7(10):3942-3960. PubMed ID: 31414096
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery strategies based on multifunctional nanocarriers for cancer therapy.
Chen H; Zhao Y; Wang H; Nie G; Nan K
Curr Drug Metab; 2012 Oct; 13(8):1087-96. PubMed ID: 22380013
[TBL] [Abstract][Full Text] [Related]
14. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
Shahbazi R; Ozpolat B; Ulubayram K
Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
[TBL] [Abstract][Full Text] [Related]
15. RNA interference: Homing in on delivery.
Baker M
Nature; 2010 Apr; 464(7292):1225-8. PubMed ID: 20414308
[No Abstract] [Full Text] [Related]
16. Multifunctional nanoplatforms co-delivering combinatorial dual-drug for eliminating cancer multidrug resistance.
Wei X; Song M; Li W; Huang J; Yang G; Wang Y
Theranostics; 2021; 11(13):6334-6354. PubMed ID: 33995661
[TBL] [Abstract][Full Text] [Related]
17. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles.
Pittella F; Miyata K; Maeda Y; Suma T; Watanabe S; Chen Q; Christie RJ; Osada K; Nishiyama N; Kataoka K
J Control Release; 2012 Aug; 161(3):868-74. PubMed ID: 22580114
[TBL] [Abstract][Full Text] [Related]
19. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K
Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
[TBL] [Abstract][Full Text] [Related]
20. Polydopamine Nanoparticles as a Versatile Molecular Loading Platform to Enable Imaging-guided Cancer Combination Therapy.
Dong Z; Gong H; Gao M; Zhu W; Sun X; Feng L; Fu T; Li Y; Liu Z
Theranostics; 2016; 6(7):1031-42. PubMed ID: 27217836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
